Video Experimental Relacionado
Updated: Jan 7, 2026

10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.5K
Respuesta clínica de la inmunoterapia dirigida al receptor de muerte celular programada 1/ ligando de muerte celular
Jie Liang1, Xinhua Chen1, Huayuan Liang2
1Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Future oncology (London, England)
|January 5, 2026
Resumen
No abstract available in PubMed .
Palabras clave:
Carcinoma de las células del anillo del selloCáncer gástricoinhibidor del punto de control inmunológicoinmunoterapiamuerte celular programada 1ligando de muerte celular programada 1Más Videos Relacionados
Videos de Conceptos Relacionados
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

